Sponsored by the Dr. Stoxx Options Letter.

With over two weeks of general market weakness behind us -- including the heaviest selling day in 5 months (today) -- it is an easy task to spot the winners.  Just look for stocks in strong uptrends, with bullish volume balance, at or near short-term highs, and showing price consolidation instead of weakness.  The following stocks meet those criteria:

Anacor Pharmaceuticals, Inc. (ANAC):

Anacor grew its EPS a whopping 219% this year, posting $53 million in income. The company reports earnings on 3/12.  The chart shows a nice uptrend with some upside room up to $54.

Canadian Solar (CSIQ):

CSIQ was the #1 stock in 2013;  2014 was a struggle, but recent price action shows better form.  Shares trade at only 10.4x eps and 6x next year's earnings on a 5-year growth rate of 36%.  The chart shows a bump up on the FSLR/SPWR news, but the recent dip to support in the trend looks like a nice entry.

Esperion Therapeutics (ESPR):

Esperion is a monster biotech with all kinds of momentum going for it.  The CEO is presenting at a big conference this Saturday...could move shares next week.  $70 is resistance here but beyond that this monster stock could go to $80+ in short order.